Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Abbvie (ABBV) PT Raised to $150 at Cowen Following Rinvoq Approval
-
Abbvie (ABBV) PT Raised to $130 at Cowen After Winning Patent Challenge
-
AbbVie to Present at the Cowen 41st Annual Health Care Conference
-
Abbvie (ABBV) PT Raised to $120 at Cowen
-
AbbVie to Present at the Cowen 40th Annual Health Care Conference
-
AbbVie (ABBV) PT Raised to $105 at Cowen After Model Update
-
Abbvie (ABBV) PT Raised to $98 at Cowen
-
Abbvie (ABBV) Management Makes A Case For No Generic Botox, Biz On Track - Cowen
-
AbbVie (ABBV) Announces Agreement to Acquire Allergan (AGN) in $63 Billion Deal
-
AbbVie to Acquire Allergan in Transformative Move for Both Companies
-
UPDATE: Abbvie (ABBV) PT Lowered to $90 at Cowen on Disappointing Guidance
-
AbbVie to Present at the Cowen Health Care Conference
-
Pre-Open Stock Movers 02/22: (W) (XOG) (VYGR) Higher (STMP) (KHC) (DBX) Lower (more...)
-
AbbVie (ABBV) Management Meeting Shows Strategies Can Overcome Challenges - Cowen
-
Abbvie (ABBV) PT Lowered to $110 at Cowen
-
AbbVie to Present at the Cowen and Company 38th Annual Health Care Conference
-
Abbvie (ABBV) PT Raised to $130 at Cowen; Big Beat
-
Cowen Upgrades Abbvie (ABBV) to Outperform
-
Abbvie (ABBV): IPR Victory Translates Into A 36% PT Increase - Cowen
-
AbbVie to Present at the Cowen and Company 37th Annual Health Care Conference
-
Notable Analyst Rating Changes 6/6: (RF) (WFT) (WMT) Upgraded; (ABBV) (CUDA) (HOG) Downgraded
-
Pre-Open Stock Movers 06/06: (VBLT) (YGE) (ONTY) Higher; (DNAI) (ADMP) (MRTX) Lower (more...)
-
Cowen Cuts Abbvie (ABBV) to Market Perform; Analyst Calls Rova-T Data at ASCO 'Underwhelming'
-
Trading Radar for 4/28: Ford (F), Amazon (AMZN), Viacom (VIAB), LinkedIn (LNKD), Pandora (P), Aetna (AET) Report
-
AbbVie to Present at Cowen and Company 36th Annual Health Care Conference
-
Notable Analyst Rating Changes 2/23: (ABBV) (TWTR) (NLY) Upgraded; (EVEP) (FCX) (X) Downgraded
-
AbbVie (ABBV) Reports Strong 3Q and Long term outlook; Cowen Reiterates Outperform
-
Cowen Remains Bullish on Galapagos NV (GLPG) After AbbVie (ABBV) Declined to Opt-In for Phase III Development of Filgotinib
-
Fresh Off Generic Sale, Allergan (AGN) is Poised for Merger of Epic Proportions (AMGN) (ABBV)
-
Streetinsider.com's Hot Lunchtime Reads 5/27: (ORCL) (AVP) (ABBV) (GILD)
-
Cowen Raises Price Target on AbbVie (ABBV) Due to Enhanced Visability
-
Streetinsider.com's Hot Lunchtime Reads 4/23: (GILD) (FB) (ABBV) (HLF)
-
Notable Analyst Rating Changes 11/14: (RTN) (ESRT) (GERN) Upgraded; ((TJX) (LULU) (WMT) Downgraded
-
Streetinsider.com's Hot Lunchtime Reads 07/11: (MSFT) (SHPG) (MCP) (ACHN)
-
Notable Analyst Rating Changes 05/07: (JCP) (ABBY) (FE) Upgraded; (WFM) (GNC) (GRPN) Downgraded
-
Cowen Starts Abbvie (ABBV) at Outperform
-
Notable Analyst Rating Changes 01/02: (WAG) (X) (MAR) Upgraded; (SKUL) (LNKD) (KSS) Downgraded